Omeros | Spese Di Vendita E Di Amministrazione

Selling And Administration Expenses Cambiamento Data
Adma Biologics USD 16.22M 1.03M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Cytokinetics USD 44.11M 4M 2023-12
Dynavax Technologies USD 39.79M 2.63M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Insmed USD 89.53M 1.1M 2023-12
Knight Therapeutics CAD 23M 1.01M 2023-09
Pacira USD 65.8M 2.15M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
United Therapeutics USD 128.6M 1000K 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Omeros Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.